Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and targeted sequencing of influenza A virus subtypes using Dutch wastewater samples from influenza season 2023-2024 and 2024-2025.

The Science of the total environment·2026
Same author

A Long-Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc-Conjugated siRNAs.

Clinical and translational science·2026
Same author

Comprehensive wastewater genomic surveillance in the Netherlands: insights into country-wide SARS-CoV-2 lineage dynamics and implications for future surveillance.

BMC public health·2025
Same author

Long-term wastewater monitoring of SARS-CoV-2 viral loads and variants at the major international passenger hub Amsterdam Schiphol Airport: A valuable addition to COVID-19 surveillance.

The Science of the total environment·2024
Same author

The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model.

Hepatology communications·2024
Same author

Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model.

Scientific reports·2024

Related Experiment Video

Updated: May 9, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Differential expression and function of human IL-12Rβ2 polymorphic variants.

Roelof A de Paus1, Marije A Geilenkirchen, Sander van Riet

  • 1Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Molecular Immunology
|August 6, 2013
PubMed
Summary

Polymorphisms in the interleukin-12 receptor beta 2 (IL-12Rβ2) gene impact immune responses. Four variants showed reduced IL-12 signaling, suggesting a role in immune and infectious diseases.

Keywords:
AutoimmunityIL-12IL-12Rβ2IL12RB2MutationPolymorphism

More Related Videos

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

Related Experiment Videos

Last Updated: May 9, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • The interleukin-12 receptor (IL-12R), composed of IL-12Rβ1 and IL-12Rβ2 subunits, is crucial for type I immune responses.
  • Polymorphisms in the IL12RB2 gene, encoding IL-12Rβ2, have been linked to immune-related diseases like Crohn's disease.
  • Proximity of IL12RB2 to IL23R raises questions about the specific contribution of IL12RB2 polymorphisms to disease associations.

Purpose of the Study:

  • To investigate the functional impact of thirteen amino acid substitutions in the IL-12Rβ2 protein.
  • To clarify the specific role of IL-12Rβ2 in mediating immune responses and its potential contribution to immune-related diseases.

Main Methods:

  • Developed a B cell line model expressing variants of IL-12Rβ2 via retroviral vectors.
  • Compared the expression and function of thirteen IL-12Rβ2 variants against a wild-type control within a consistent genetic background.

Main Results:

  • Four IL-12Rβ2 variants (N271Y, R313G, A604V, L808R) exhibited significantly reduced IL-12 responses compared to the wild-type.
  • Two of these identified variants are relatively common in certain populations.

Conclusions:

  • Specific IL-12Rβ2 variants can impair IL-12 signaling pathways.
  • Common IL-12Rβ2 variants may serve as valuable markers in future genetic association studies for infectious and immune-related diseases.